Insider filing · ECAT

BlackRock, Inc. bought $1.3M of BlackRock ESG Capital Allocation Term (ECAT)

Executed Mar 6 2025, disclosed Mar 6 2025, the same day.

Over the 21 trading sessions from the disclosed entry session (Mar 6 2025), the stock returned -5.4% (delay-adjusted); from the execution session (Mar 6 2025), -5.4%. Derived: entry at the session's open, exit at the close 20 sessions later.

BI BlackRock, Inc. Other profile →

BlackRock, Inc. (Other) filed 15 Form 4 reports as a reporting entity in the past 24 months (15 purchases, 0 sales), most often in BlackRock ESG Capital Allocation Term Trust (ECAT). Across 14 priced purchase filings, the average 21-session return was -7.8% from execution and -8.0% from disclosure (delay-adjusted; derived). The largest single filing was $1.7M of ECAT (101,600 sh × $16.31, as filed), executed Mar 20 2025.

ECAT BlackRock ESG Capital Allocation Term Trust ECAT · 140 filings in 24 months ticker →

Financial Services

Insider filings, newest first→ View the original filing at www.sec.gov→